Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Bone. 2013 Dec;57(2):386-91. doi: 10.1016/j.bone.2013.09.002. Epub 2013 Sep 17.
Fibrodysplasia ossificans progressiva, an ultra-rare and disabling genetic disorder of skeletal malformations and progressive heterotopic ossification (HO), is the most catastrophic condition of skeletal metamorphosis in humans. We studied 72 patients with FOP in China and analyzed their phenotypes and genotypes comprising the world's largest ethnically homogeneous population of FOP patients. Ninety-nine percent of patients (71/72 cases) were of Han nationality; and 1% of patients (1/72 cases) were of Hui nationality. Based on clinical examination, 92% of patients (66/72 cases) had classic FOP; 4% of patients (3/72 cases) were FOP-plus; and 4% of patients (3/72) were FOP variants. Importantly, all individuals with FOP had mutations in the protein-coding region of activin A receptor, type I/activin-like kinase 2 (ACVR1/ALK2). Ninety-seven percent of FOP patients (70/72 cases) had the canonical c.617G>A (p.R206H) mutation, while 3% of FOP patients (2/72 cases) had variant mutations in ACVR1/ALK2. Taken together, the genotypes and phenotypes of individuals with FOP from the Han nationality in China are similar to those reported elsewhere and support the fidelity of this ultra-rare disorder in the world's most highly populated nation and across wide racial, ethnic, gender and geographic distributions.
进行性骨化性纤维发育不良,一种罕见的骨骼畸形和进行性异位骨化(HO)的遗传性疾病,是人类骨骼变形中最严重的疾病。我们在中国研究了 72 名 FOP 患者,并对他们的表型和基因型进行了分析,这些患者构成了世界上最大的同种族 FOP 患者群体。99%的患者(71/72 例)为汉族;1%的患者(1/72 例)为回族。根据临床检查,92%的患者(66/72 例)为经典 FOP;4%的患者(3/72 例)为 FOP-plus;4%的患者(3/72 例)为 FOP 变异型。重要的是,所有 FOP 患者的激活素 A 受体 I 型/激活素样激酶 2(ACVR1/ALK2)蛋白编码区都有突变。97%的 FOP 患者(70/72 例)存在典型的 c.617G>A(p.R206H)突变,而 3%的 FOP 患者(2/72 例)存在 ACVR1/ALK2 的变异突变。总之,来自中国汉族的 FOP 患者的基因型和表型与其他地方报道的相似,支持了这种罕见疾病在世界人口最多的国家以及广泛的种族、民族、性别和地理分布中的真实性。